CHOC is one of the state’s largest referral centers for the newborn screening program, which checks babies for many serious genetic disorders.
Much of infantile spasms research focuses on visual analysis of a patient’s EEG, whereas Dr. Daniel Shrey’s research uses a computation.
It’s possible that the plasma of recovered COVID-19 patients may have antibodies that could help in the treatment of others with COVID-19.
Nurses and other participants from a range of disciplines will work in teams to devise answers, develop prototypes and pitch solutions.
A recently completed pilot program at CHOC and other California clinical sites helped target a baby’s specific genetic disease in just days.
Along with providing access to clinical trials for CAR T-cell therapy and other immunotherapy, CHOC is a certified KYMRIAH treatment center.